This is a comparative, open label, parallel group, non interventional study to further demonstrate the effectiveness and tolerability of Ectoin® Rhinitis Nasal Spray. In addition the effectiveness and safety shall be compared to a Sinupret forte. The patient applies Ectoin® Rhinitis Nasal Spray or takes Sinupret forte according to the instructions for use. The observation takes place over a period of 14 days. Response to treatment is recorded at day 7 and day 14 by the physician and in daily by the patient in a dairy.
Study Type
OBSERVATIONAL
Enrollment
66
Ectoin Rhinitis Nasal Spray
Dr. med. Georg Krueckels
Aachen, Germany
Dr. med. Martin Sondermann
Aachen, Germany
Dr. med. Norbert Pasch
Aachen, Germany
Peter Hinterkausen
Cologne, Germany
Taufik Shahab
Changes in the symptoms of acute Rhinosinusitis assessed by the EPOS- Sinusitis-Symptom-Score
Time frame: day 1, day 7, day 14
Quality of Life questionnaire (Rhino QoL)
Time frame: day 1, day 7, day 14
Rhinoscopy
Time frame: day 1, day 7, day 14
Patient's and physician's judgment of efficacy
Time frame: day 7, day 14
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Cologne, Germany
Dr. med. Wilhelm Schuetz
Jülich, Germany